Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
収録刊行物
-
- The Lancet
-
The Lancet 398 (10303), 843-855, 2021-09
Elsevier BV